Reply by authors (Changes in Use of Oral Androgen Pathway Directed Medications during the COVID-19 Era)

Author reply to editorials regarding the oral androgen pathway medications IQVIA paper

Reply by authors (Antegrade Instillation of UGN-101 [Mitomycin for Pyelocalyceal Solution] for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience)

Author reply to editorials regarding the antigrade UGN-101 initial experiences paper

Re: Delayed Radical Prostatectomy is Not Associated with Adverse Oncological Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic

We wrote a reply commenting on the statistical methods used.